New infant vaccine shows promising immune response
NCT ID NCT03188692
Summary
This completed Phase 3 study tested the safety and effectiveness of an investigational combination vaccine called BK1310 in healthy infants. The vaccine aimed to protect against several serious childhood diseases, including Hib, diphtheria, pertussis (whooping cough), tetanus, and polio. Researchers measured whether infants developed protective antibody levels after receiving the injection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNIZATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational site 1
Chiba, Japan
-
Investigational site 2
Tokyo, Japan
-
Investigational site 3
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.